Archive ready

2024年3月期 決算短信〔日本基準〕(連結)

https://www.cawachi.co.jp/wp/wp-content/uploads/ir-tan20240426.pdf
May 13, 2026 at 12:45 AM JSTThe archive page, viewer, and downloads use this saved version.
May 13, 2026 at 12:45 AM JST·www.cawachi.co.jp

The evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.

Saved PDF

2024年3月期 決算短信〔日本基準〕(連結)

StartedMay 13, 2026 at 12:45 AM JST
File size0.29 MB
SHA-256b00a90a5356e43c662b546badf57d99b9d76d2fbb5e6c2d7ccf237c6266068f2
About this pageAI generated

This document presents the financial results for the fiscal year ending March 2024 of Kawachi Drugstore Co., Ltd. The consolidated sales for the fiscal year reached 285,960 million yen, marking a 1.5% increase compared to the previous year. Operating profit was 7,601 million yen, ordinary profit was 8,609 million yen, and net profit attributable to shareholders was 4,713 million yen, all exceeding the previous year's figures. The dividend was set at 80 yen, with a payout ratio of 37.9%. The economic environment is gradually recovering from the impact of COVID-19, although rising prices have increased the burden of living costs.